Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 842

2.
3.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.

4.

Riociguat for the treatment of pulmonary hypertension.

Hambly N, Granton J.

Expert Rev Respir Med. 2015;9(6):679-95. doi: 10.1586/17476348.2015.1106316. Epub 2015 Nov 24. Review.

PMID:
26599488
5.

Use of Coils and a Pulmonary Vasodilator to Reduce Pulmonary Hypertension in a Patient with Interstitial Pneumonia and Scleroderma.

Teguh Ryanto GR, Nakayama K, Takaya T, Fujimoto D, Kinutani H, Shinkura Y, Mori S, Okada T, Nishii T, Kono A, Shinke T, Emoto N, Hirata K.

Intern Med. 2015;54(21):2721-6. doi: 10.2169/internalmedicine.54.4976. Epub 2015 Nov 1.

6.

EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.

Kandhi S, Qin J, Froogh G, Jiang H, Luo M, Wolin MS, Huang A, Sun D.

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 15;309(12):L1478-86. doi: 10.1152/ajplung.00208.2015. Epub 2015 Oct 23.

PMID:
26498250
7.

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.

Mandal J, Roth M, Costa L, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D.

Respiration. 2015;90(5):357-68. doi: 10.1159/000439228. Epub 2015 Oct 9.

PMID:
26447811
8.

Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.

Mizuno S, Ishizaki T, Toga H, Sakai A, Isakova J, Taalaibekova E, Baiserkeev Z, Kojonazarov B, Aldashev A.

Biomed Res Int. 2015;2015:196904. doi: 10.1155/2015/196904. Epub 2015 Aug 26.

9.

MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.

Kolditz M, Seyfarth HJ, Wilkens H, Ewert R, Bollmann T, Dinter C, Hertel S, Klose H, Opitz C, Grünig E, Höffken G, Halank M.

Lung. 2015 Dec;193(6):901-10. doi: 10.1007/s00408-015-9802-y. Epub 2015 Sep 12.

PMID:
26363916
10.

A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung.

Zhao YD, Chu L, Lin K, Granton E, Yin L, Peng J, Hsin M, Wu L, Yu A, Waddell T, Keshavjee S, Granton J, de Perrot M.

PLoS One. 2015 Aug 28;10(8):e0134958. doi: 10.1371/journal.pone.0134958. eCollection 2015.

11.

Adrenomedullin induces pulmonary vasodilation but does not attenuate pulmonary hypertension in a sheep model of acute pulmonary embolism.

Lagos-Carvajal AP, Teixeira-Neto FJ, Becerra-Velásquez DR, Diniz MS, Klein AV, Rocha TL, Dias-Junior CA.

Life Sci. 2015 Oct 15;139:139-44. doi: 10.1016/j.lfs.2015.08.013. Epub 2015 Aug 24.

PMID:
26316450
12.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators.

N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687.

13.

Severe pulmonary hypertension in lung disease: phenotypes and response to treatment.

Brewis MJ, Church AC, Johnson MK, Peacock AJ.

Eur Respir J. 2015 Nov;46(5):1378-89. doi: 10.1183/13993003.02307-2014. Epub 2015 Aug 20.

PMID:
26293503
14.

Ambrisentan for the treatment of adults with pulmonary arterial hypertension: a review.

Peacock AJ, Zamboni W, Vizza CD.

Curr Med Res Opin. 2015;31(9):1793-807. doi: 10.1185/03007995.2015.1074890. Epub 2015 Aug 27. Review.

PMID:
26196225
15.

Reversal of diffuse patchy pattern in lung perfusion scan in a case of severe pulmonary arterial hypertension.

Kodama Y, Abe K, Hosokawa K, Ohtani K, Nagao M, Hirooka Y, Sunagawa K.

Heart Lung. 2015 Sep-Oct;44(5):451-2. doi: 10.1016/j.hrtlng.2015.06.005. Epub 2015 Jun 29.

PMID:
26138776
16.

Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy.

Yu B, Muenster S, Blaesi AH, Bloch DB, Zapol WM.

Sci Transl Med. 2015 Jul 1;7(294):294ra107. doi: 10.1126/scitranslmed.aaa3097.

PMID:
26136478
17.

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension.

McLaughlin V, Channick RN, Ghofrani HA, Lemarié JC, Naeije R, Packer M, Souza R, Tapson VF, Tolson J, Al Hiti H, Meyer G, Hoeper MM.

Eur Respir J. 2015 Aug;46(2):405-13. doi: 10.1183/13993003.02044-2014. Epub 2015 Jun 25.

PMID:
26113687
18.

Inhaled Therapies for Pulmonary Hypertension.

Hill NS, Preston IR, Roberts KE.

Respir Care. 2015 Jun;60(6):794-802; discussion 802-5. doi: 10.4187/respcare.03927. Review.

19.

Worsening gradient of aortic stenosis with treatment of pulmonary arterial hypertension in scleroderma.

Pietras DA, Lopez FR, Peréz R, López-Candales A, Elwing J.

Bol Asoc Med P R. 2015 Jan-Mar;107(1):41-4. Review.

PMID:
26035984
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk